| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |